SALT LAKE CITY, UT--(Marketwired - Jan 8, 2014) - Q Therapeutics, Inc., an emerging biotechnology company developing innovative cell therapy products for the treatment of debilitating diseases of the central nervous system, today announced that the Company is scheduled to present at the Biotech Showcase™ 2014 to be held next week in San Francisco, California, January 13-15, 2014, during the JP Morgan Healthcare Conference.
The Biotech Showcase is an investor and partnering conference devoted to providing private and public biotechnology and life sciences companies with an opportunity to present to, and meet with, investors and pharmaceutical executives in one place during the course of one of the industry's largest annual healthcare investor conferences.
EVENT AT A GLANCE
Deborah Eppstein, PhD - President and CEO
Monday, January 13, 2014
2:00 PM PT
Mission II Room -- Third Floor
Parc 55 Wyndham San Francisco -- Union Square
55 Cyril Magnin Street
San Francisco, California
NOTE TO PRESS:
Qualified media are also invited to attend the event on a complimentary basis. Please contact Kelly Rogers from EBD Group at 760-930-0500 or firstname.lastname@example.org to register for the event. To arrange one-on-one interviews with Deborah Eppstein, PhD, President and CEO of Q Therapeutics, please contact Erin Palmer at Hanover|Elite at 407-585-1080 or via email at QCEL@hanoverelite.com for scheduling details.
About Biotech Showcase
Biotech Showcase™ is an investor and partnering conference devoted to providing private and public biotechnology and life sciences companies with an opportunity to present to, and meet with, investors and pharmaceutical executives in one place during the course of one of the industry's largest annual healthcare investor conferences. Investors and biopharmaceutical executives from around the world gather in San Francisco during this critical week which is widely viewed as setting the tone for the coming year. Now in its sixth year, this rapidly growing conference features multiple tracks of presenting companies, plenary sessions, workshops, networking, and an opportunity to schedule one-to-one meetings. In addition to biopharmaceutical and life science company executives, Biotech Showcase delegates include investors in private and public companies, sector analysts, bankers and industry professionals. Biotech Showcase is produced by Demy Colton Life Science Advisors and EBD Group. Both organizations have a long history of producing high quality programs that support the biotechnology and broader life sciences industry. For more information and online registration please visit our conference website at www.ebdgroup.com/bts.
About Q Therapeutics, Inc.
Headquartered in Salt Lake City, Utah, Q Therapeutics, Inc. is a fully reporting, non-trading company, engaged in developing adult stem cell therapies to treat debilitating diseases of the central nervous system. The Company's first product, Q-Cells®, is a cell-based therapeutic intended to restore or preserve normal activity of neurons by providing essential support functions that occur in healthy central nervous system tissues. Q-Cells may be applicable to a wide range of central nervous system diseases, including demyelinating conditions such as multiple sclerosis, transverse myelitis, cerebral palsy and stroke; as well as other neurodegenerative diseases and injuries, such as ALS (Lou Gehrig's disease), Huntington's disease, spinal cord injury, traumatic brain injury, Parkinson's disease and Alzheimer's disease. Q Therapeutics' initial clinical target is ALS, with a first IND submission expected in 2014. For more information, visit www.qthera.com.